MoneyWorks4Me

Gland Pharma - Quaterly Results

04 Nov 2024 Evaluate
The Revenue for the quarter ended  September 2024 of Rs. 10629.90 millions grew by 5.18 % from Rs. 10106.67 millions.Modest increase of 9.39% in the Net Profit was reported from. 2575.27 millions to Rs. 2817.10  millions.Operating profit for the quarter ended September 2024 rose to 4216.03 millions as compared to 3882.13 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 10629.90 10106.67 5.18 20750.14 18947.37 9.51 41674.28 36165.28 15.23
Other Income 578.03 411.14 40.59 1062.93 763.21 39.27 1666.66 2404.64 -30.69
PBIDT 4216.03 3882.13 8.60 7636.46 6827.82 11.84 15754.47 12590.13 25.13
Interest 1.72 9.14 -81.18 10.83 25.10 -56.85 78.43 74.14 5.79
PBDT 4214.31 3872.99 8.81 7625.63 6802.72 12.10 15676.04 11951.38 31.17
Depreciation 416.15 402.36 3.43 824.32 792.18 4.06 1621.07 1467.36 10.48
PBT 3798.16 3470.63 9.44 6801.31 6010.54 13.16 14054.97 10484.02 34.06
TAX 981.06 895.36 9.57 1755.00 1559.45 12.54 3621.72 2725.76 32.87
Deferred Tax 17.74 29.53 -39.93 29.56 104.82 -71.80 246.84 -27.99 -981.89
PAT 2817.10 2575.27 9.39 5046.31 4451.09 13.37 10433.25 7758.26 34.48
Equity 164.75 164.70 0.03 164.75 164.70 0.03 164.71 164.70 0.01
PBIDTM(%) 39.66 38.41 3.26 36.80 36.04 2.13 37.80 34.81 8.59
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..